About Us

You are at the location of:Home>About Us>Publications

1. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α. Lu M, Ge Q, Wang G, Luo Y, Wang X, Jiang W, Liu X, Wu CL, Xiao Y, Wang X. Cell Death Dis. 2018 Oct 12;9(10):1046. doi: 10.1038/s41419-018-1109-5.

 

2. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y, Chen L, Wang G, Cheng S, Qian K, Liu X, Wu CL, Xiao Y, Wang X. J Cell Physiol. 2018. doi: 10.1002/jcp.27692.

 

3. Prognostic value of a gene signature in clear cell renal cell carcinoma. Chen L, Luo Y, Wang G, Qian K, Qian G, Wu CL, Dan HC, Wang X, Xiao Y. J Cell Physiol. 2018. doi: 10.1002/jcp.27700.

 

4. Co-expression network analysis of biomarkers for adrenocortical carcinoma. Yuan L, Qian G, Chen L, Wu CL, Dan HC, Xiao Y, Wang X. Front Genet. 2018 Aug 15;9:328. doi: 10.3389/fgene.2018.00328.

 

5. The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER. Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G. Onco Targets Ther. 2018 Jun 19;11:3551-3560. doi: 10.2147/OTT.S160752.

 

6. Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma. Wang J, Yuan L, Liu X, Wang G, Zhu Y, Qian K, Xiao Y, Wang X. Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473.

 

7. Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer. Tang J, Kong D, Cui Q, Wang K, Zhang D, Yuan Q, Liao X, Gong Y, Wu G. PeerJ. 2018 May 4;6:e4674. doi: 10.7717/peerj.4674.

 

8. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis. Chen L, Yuan L, Qian K, Qian G, Zhu Y, Wu CL, Dan HC, Xiao Y, Wang X. Front Physiol. 2018 Apr 18;9:399. doi: 10.3389/fphys.2018.00399.

 

9. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. Yuan L, Zeng G, Chen L, Wang G, Wang X, Cao X, Lu M, Liu X, Qian G, Xiao Y, Wang X. Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574.

 

10. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes. Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G. World J Surg Oncol. 2018 Mar 5;16(1):45. doi: 10.1186/s12957-018-1340-7.

 

11. Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells. You C, Sun Y, Zhang S, Tang G, Zhang N, Li C, Tian X, Ma S, Luo Y, Sun W, Wang F, Liu X, Xiao Y, Gong Y, Zhang J, Xie C. Int J Biol Sci. 2018 Feb 9;14(2):217-227. doi: 10.7150/ijbs.22811.

 

12. The applied value of medical history, physical examination, colour-Doppler ultrasonography and testis scintigraphy in the differential diagnosis of acute scrotum.Yan Y, Chen S, Chen Z, Pei X, Zhou J, Xiao Y, Wang X. Andrologia. 2018 Feb 20. doi: 10.1111/and.12973.

 

13. FePt-Cys nanoparticles induce ROS-dependent cell toxicity, and enhance chemo-radiation sensitivity of NSCLC cells in vivo and in vitro. Sun Y, Miao H, Ma S, Zhang L, You C, Tang F, Yang C, Tian X, Wang F, Luo Y, Lin X, Wang H, Li C, Li Z, Yu H, Liu X, Xiao Y, Gong Y, Zhang J, Quan H, Xie C. Cancer Lett. 2018 Apr 1;418:27-40. doi: 10.1016/j.canlet.2018.01.024.

 

14. Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer. Li S, Liu X, Liu T, Meng X, Yin X, Fang C, Huang D, Cao Y, Weng H, Zeng X, Wang X. Front Physiol. 2017 Nov 28;8:947. doi: 10.3389/fphys.2017.00947.

 

15. Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer. Ye R, Wei B, Li S, Liu W, Liu J, Qiu L, Wu X, Zhao Z, Li J. Oncotarget. 2017 Oct 19;8(57):97260-97272. doi: 10.18632/oncotarget.21919.

 

16. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma. Chen L, Yuan L, Wang Y, Wang G, Zhu Y, Cao R, Qian G, Xie C, Liu X, Xiao Y, Wang X. Int J Biol Sci. 2017 Nov 1;13(11):1361-1372. doi: 10.7150/ijbs.21657.

 

17. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co-expression analysis. Yuan L, Chen L, Qian K, Wang G, Lu M, Qian G, Cao X, Jiang W, Xiao Y, Wang X. Oncol Rep. 2018 Feb;39(2):525-536. doi: 10.3892/or.2017.6132.

 

18. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells. Cao R, Wang G, Qian K, Chen L, Ju L, Qian G, Wu CL, Dan HC, Jiang W, Wu M, Xiao Y, Wang X. Cancer Lett. 2018 Feb 1;414:278-293. doi: 10.1016/j.canlet.2017.11.015.

 

19. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC). Yuan L, Chen L, Qian K, Qian G, Wu CL, Wang X, Xiao Y. Genom Data. 2017 Nov 4;14:132-140. doi: 10.1016/j.gdata.2017.10.006.

 

20. Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways. Hu Q, Wang G, Peng J, Qian G, Jiang W, Xie C, Xiao Y, Wang X. Biomed Res Int. 2017;2017:3781904. doi: 10.1155/2017/3781904.

 

21. Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. Yang X, Gong Y, He Q, Licht JD, Liaw L, Friesel RE. J Cell Biochem. 2018 Apr;119(4):3267-3279. doi: 10.1002/jcb.26486.

 

22. Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis. Yuan L, Shu B, Chen L, Qian K, Wang Y, Qian G, Zhu Y, Cao X, Xie C, Xiao Y, Wang X. Oncotarget. 2017 Jul 28;8(41):70508-70520. doi: 10.18632/oncotarget.19733.

 

23. Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop. Cao R, Wang G, Qian K, Chen L, Qian G, Xie C, Dan HC, Jiang W, Wu M, Wu CL, Xiao Y, Wang X. J Cancer. 2017 Jul 20;8(12):2282-2295. doi: 10.7150/jca.19967.

 

24. PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes. Zhou Y, Miao J, Wu H, Tang H, Kuang J, Zhou X, Peng Y, Hu D, Shi D, Deng W, Cao X, Zhao C, Xie C. Oncotarget. 2017 Apr 19;8(31):51210-51223. doi: 10.18632/oncotarget.17214.